Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Regulator of calcineurin 1 (RCAN1) and neuronal apoptosis

FY 2009-10

Summary
Alzheimer's disease (AD) is characterized by pathology such as neuritic plaques, neurofibrillary tangles, and progressive neuronal loss. Studies have shown that the regulator of calcineurin 1 (RCAN1) gene is overexpressed in the brains of AD patients compared to age-matched controls. Also, neurons with upregulated RCAN1 transcription were observed to be more vulnerable to apoptotic cell death. The results suggest that abnormal RCAN1 gene expression and function may promote neuronal apoptosis in AD. Therefore, elucidating the mechanism of RCAN1 transcription and translation, and the pathway of RCAN1-mediated apoptosis, may reveal novel therapeutic targets for AD. The first aim is to define the mechanism of differential RCAN1 transcription by A-beta, gluticocorticoid, and calcium. Dexamethasone, A-beta, and A23187 will be applied to cells transfected with exon 1 and exon 4 of the RCAN1 gene, followed by quantification of gene expression using the luciferase assay. Upregulation of gene expression will be confirmed by performing RT-PCR and Western blot. The experiments will determine if differential RCAN1 transcription is controlled by two alternative promoters and the mechanism by which A-beta, gluticocorticoids and calcium regulate RCAN1 gene expression. The second aim is to identify the molecular pathway mediating RCAN1-induced neuronal apoptosis. To investigate if caspase-3 mediates RCAN1-induced neuronal apoptosis, caspase-3 cleavage will be assayed in primary rat neurons overexpressing RCAN1 in the presence of A23187, H2O2 and A-beta treatment. Also, neurons overexpressing RCAN1 derived from caspase-3-knockout mice and wild-type mice will be challenged with H2O2 and analyzed for apoptosis to determine whether caspase-3 is required for RCAN1-induced apoptosis. The third aim is to study the biological function of RCAN1 by performing neuronal apoptosis assays and behavioural tests on transgenic mice that overexpress the RCAN1 gene.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
201576
Name
Ko Rebecca W
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Regulator of calcineurin 1 (RCAN1) and neuronal apoptosis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Rcan1 Gene
Abstract
Alzheimer's disease (AD) is characterized by pathology such as neuritic plaques, neurofibrillary tangles, and progressive neuronal loss. Studies have shown that the regulator of calcineurin 1 (RCAN1) gene is overexpressed in the brains of AD patients compared to age-matched controls. Also, neurons with upregulated RCAN1 transcription were observed to be more vulnerable to apoptotic cell death. The results suggest that abnormal RCAN1 gene expression and function may promote neuronal apoptosis in AD. Therefore, elucidating the mechanism of RCAN1 transcription and translation, and the pathway of RCAN1-mediated apoptosis, may reveal novel therapeutic targets for AD. The first aim is to define the mechanism of differential RCAN1 transcription by A-beta, gluticocorticoid, and calcium. Dexamethasone, A-beta, and A23187 will be applied to cells transfected with exon 1 and exon 4 of the RCAN1 gene, followed by quantification of gene expression using the luciferase assay. Upregulation of gene expression will be confirmed by performing RT-PCR and Western blot. The experiments will determine if differential RCAN1 transcription is controlled by two alternative promoters and the mechanism by which A-beta, gluticocorticoids and calcium regulate RCAN1 gene expression. The second aim is to identify the molecular pathway mediating RCAN1-induced neuronal apoptosis. To investigate if caspase-3 mediates RCAN1-induced neuronal apoptosis, caspase-3 cleavage will be assayed in primary rat neurons overexpressing RCAN1 in the presence of A23187, H2O2 and A-beta treatment. Also, neurons overexpressing RCAN1 derived from caspase-3-knockout mice and wild-type mice will be challenged with H2O2 and analyzed for apoptosis to determine whether caspase-3 is required for RCAN1-induced apoptosis. The third aim is to study the biological function of RCAN1 by performing neuronal apoptosis assays and behavioural tests on transgenic mice that overexpress the RCAN1 gene.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ko, Rebecca W
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~